Emerging functions of the EGFR in cancer

The physiological function of the epidermal growth factor receptor (EGFR) is to regulate epithelial tissue development and homeostasis. In pathological settings, mostly in lung and breast cancer and in glioblastoma, the EGFR is a driver of tumorigenesis. Inappropriate activation of the EGFR in cancer mainly results from amplification and point mutations at the genomic locus, but transcriptional upregulation or ligand overproduction due to autocrine/paracrine mechanisms has also been described. Moreover, the EGFR is increasingly recognized as a biomarker of resistance in tumors, as its amplification or secondary mutations have been found to arise under drug pressure. This evidence, in addition to the prominent function that this receptor plays in normal epithelia, has prompted intense investigations into the role of the EGFR both at physiological and at pathological level. Despite the large body of knowledge obtained over the last two decades, previously unrecognized (herein defined as ‘noncanonical’) functions of the EGFR are currently emerging. Here, we will initially review the canonical ligand‐induced EGFR signaling pathway, with particular emphasis to its regulation by endocytosis and subversion in human tumors. We will then focus on the most recent advances in uncovering noncanonical EGFR functions in stress‐induced trafficking, autophagy, and energy metabolism, with a perspective on future therapeutic applications.

[1]  Marie-Lena I. E. Harwardt,et al.  Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy , 2017, eLife.

[2]  P. P. Di Fiore,et al.  Behind the Scenes: Endo/Exocytosis in the Acquisition of Metastatic Traits. , 2017, Cancer research.

[3]  P. Bork,et al.  The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR , 2016, The Journal of cell biology.

[4]  M. McNiven,et al.  A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.

[5]  A. Citri,et al.  Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling , 2007, Oncogene.

[6]  N. Sauvonnet,et al.  Endophilin marks and controls a clathrin-independent endocytic pathway , 2014, Nature.

[7]  John Foley,et al.  Functional selectivity of EGF family peptide growth factors: implications for cancer. , 2009, Pharmacology & therapeutics.

[8]  T. Tsakiridis,et al.  Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. , 2016, Metabolism: clinical and experimental.

[9]  Kevin Carroll,et al.  Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) , 2005, The Lancet.

[10]  A. Sobel,et al.  The Journal of Biological Chemistry. , 2009, Nutrition reviews.

[11]  J. Schlessinger,et al.  Receptor tyrosine kinases: legacy of the first two decades. , 2014, Cold Spring Harbor perspectives in biology.

[12]  C. Futter,et al.  EGF receptor trafficking: consequences for signaling and cancer , 2014, Trends in cell biology.

[13]  S. Sigismund,et al.  Chapter Six - The Ubiquitin Network in the Control of EGFR Endocytosis and Signaling. , 2016, Progress in molecular biology and translational science.

[14]  H. Kajiho,et al.  RAB2A controls MT1‐MMP endocytic and E‐cadherin polarized Golgi trafficking to promote invasive breast cancer programs , 2016, EMBO reports.

[15]  Xuejun Jiang,et al.  Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. , 2006, Molecular cell.

[16]  C. A. Guyer,et al.  Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells. , 2003, Experimental cell research.

[17]  F. Ali-Osman,et al.  EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis , 2011, Molecular Cancer.

[18]  S. Keir,et al.  EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity. , 2010, Cancer letters.

[19]  A. Bardelli,et al.  MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations , 2016, Science Translational Medicine.

[20]  Y. Yarden,et al.  Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. , 2016, Seminars in cell & developmental biology.

[21]  S. Horvath,et al.  EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy , 2009, Science Signaling.

[22]  I. Pastan,et al.  Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes , 1984, Cell.

[23]  C. Futter,et al.  Membrane contacts between endosomes and ER provide sites for PTP1B–epidermal growth factor receptor interaction , 2010, Nature Cell Biology.

[24]  F. Bosch,et al.  Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer , 2012, Nature Medicine.

[25]  T. Miyake,et al.  Epidermal Growth Factor Receptor Translocation to the Mitochondria , 2009, The Journal of Biological Chemistry.

[26]  M. Moran,et al.  Proteomic Analysis of the Epidermal Growth Factor Receptor (EGFR) Interactome and Post-translational Modifications Associated with Receptor Endocytosis in Response to EGF and Stress* , 2014, Molecular & Cellular Proteomics.

[27]  A. Scott,et al.  The Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor AG1478 Increases the Formation of Inactive Untethered EGFR Dimers , 2007, Journal of Biological Chemistry.

[28]  Peter J Verveer,et al.  Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum , 2002, Science.

[29]  D. Yamazaki,et al.  Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. , 2003, Developmental cell.

[30]  A. Takaoka,et al.  Comparing antibody and small-molecule therapies for cancer , 2006, Nature Reviews Cancer.

[31]  G. Carpenter,et al.  All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.

[32]  M. Oksvold,et al.  UV-Radiation-Induced Internalization of the Epidermal Growth Factor Receptor Requires Distinct Serine and Tyrosine Residues in the Cytoplasmic Carboxy-Terminal Domain , 2004, Radiation research.

[33]  A. Bardelli,et al.  Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer , 2016, Nature Communications.

[34]  B. van Deurs,et al.  EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. , 2007, Carcinogenesis.

[35]  Shuichi Takayama,et al.  Lateral propagation of EGF signaling after local stimulation is dependent on receptor density. , 2002, Developmental cell.

[36]  M. Lisanti,et al.  Epidermal Growth Factor Receptor Exposed to Oxidative Stress Undergoes Src- and Caveolin-1-dependent Perinuclear Trafficking* , 2006, Journal of Biological Chemistry.

[37]  D. Hochhauser,et al.  Stress-specific p38 MAPK activation is sufficient to drive EGFR endocytosis but not its nuclear translocation , 2017, Journal of Cell Science.

[38]  Isabelle Robert,et al.  Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer , 2007, Proceedings of the National Academy of Sciences.

[39]  A. Kiyatkin,et al.  EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics , 2017, Cell.

[40]  G. Voeltz,et al.  Structure and function of ER membrane contact sites with other organelles , 2015, Nature Reviews Molecular Cell Biology.

[41]  D. Wheeler,et al.  The nuclear epidermal growth factor receptor signaling network and its role in cancer. , 2011, Discovery medicine.

[42]  R. Derynck,et al.  Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.

[43]  G. Mills,et al.  Genomic amplicons target vesicle recycling in breast cancer. , 2009, The Journal of clinical investigation.

[44]  Sandra L Schmid,et al.  Cargo and Dynamin Regulate Clathrin-Coated Pit Maturation , 2009, PLoS biology.

[45]  R. Roskoski The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.

[46]  C. Pyke,et al.  Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy. , 2010, Cancer research.

[47]  J. Settleman,et al.  EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling , 2012, Growth factors.

[48]  E. Skarpen,et al.  UV induces tyrosine kinase-independent internalisation and endosome arrest of the EGF receptor. , 2002, Journal of cell science.

[49]  K. Dittmann,et al.  Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK , 2008, Molecular Cancer.

[50]  M. Salido,et al.  Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer , 2015, Clinical Cancer Research.

[51]  N. Copeland,et al.  The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.

[52]  G. Carpenter,et al.  Interaction of activated EGF receptors with coated pit adaptins. , 1993, Science.

[53]  F. Hirsch,et al.  Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies. , 2013, European journal of cancer.

[54]  Yih-Leong Chang,et al.  Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC , 2015, Oncotarget.

[55]  Matthew West,et al.  Endoplasmic reticulum–endosome contact increases as endosomes traffic and mature , 2013, Molecular biology of the cell.

[56]  E. Wagner,et al.  Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.

[57]  Naveid A Ali,et al.  The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking , 2015, Science Signaling.

[58]  Davide Mazza,et al.  Reticulon 3–dependent ER-PM contact sites control EGFR nonclathrin endocytosis , 2017, Science.

[59]  A. Ciliberto,et al.  Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells , 2015, Nature Communications.

[60]  W. Bou-Assaly,et al.  Cetuximab (Erbitux) , 2010, American Journal of Neuroradiology.

[61]  Gordon B. Mills,et al.  Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.

[62]  Marino Zerial,et al.  Rab Proteins and the Compartmentalization of the Endosomal System , 2014 .

[63]  J. Hurley,et al.  The ESCRT machinery at a glance , 2009, Journal of Cell Science.

[64]  J. Schlessinger,et al.  The EGFR family: not so prototypical receptor tyrosine kinases. , 2014, Cold Spring Harbor perspectives in biology.

[65]  R. Puertollano,et al.  Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization , 2006, Traffic.

[66]  H. Lo,et al.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. , 2012, Cancer letters.

[67]  G. Scita,et al.  Membrane and actin dynamics interplay at lamellipodia leading edge. , 2013, Current opinion in cell biology.

[68]  Yan Luo,et al.  Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. , 2016, Cellular signalling.

[69]  Sophie Dahan,et al.  Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction. , 2016, Annual review of biochemistry.

[70]  B. Shi,et al.  EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer , 2017, Molecular Cancer.

[71]  W. Cavenee,et al.  Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Carraway,et al.  Epidermal Growth Factor Receptor Activation under Oxidative Stress Fails to Promote c-Cbl Mediated Down-regulation* , 2002, The Journal of Biological Chemistry.

[73]  J. Debnath,et al.  Autophagy and cancer metabolism. , 2014, Methods in enzymology.

[74]  H. Esumi,et al.  Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma* , 2014, The Journal of Biological Chemistry.

[75]  John Kuriyan,et al.  An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.

[76]  M. Hung,et al.  Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.

[77]  G. Voeltz,et al.  ER Contact Sites Define the Position and Timing of Endosome Fission , 2014, Cell.

[78]  Y. Yarden,et al.  The C‐terminus of the kinase‐defective neuregulin receptor ErbB‐3 confers mitogenic superiority and dictates endocytic routing , 1999, The EMBO journal.

[79]  G. Mills,et al.  Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments , 2007 .

[80]  David Owen,et al.  Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. , 2014, Cold Spring Harbor perspectives in biology.

[81]  D. Hochhauser,et al.  WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway , 2015, Nature Communications.

[82]  M. McNiven,et al.  Increased Expression of the Large GTPase Dynamin 2 Potentiates Metastatic Migration and Invasion of Pancreatic Ductal Carcinoma , 2011, Oncogene.

[83]  Salvatore Pece,et al.  Endocytosis and cancer. , 2004, Current opinion in cell biology.

[84]  Harvey T. McMahon,et al.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.

[85]  P. Transidico,et al.  Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Tobias Meyer,et al.  A polarized Ca2+, diacylglycerol, and STIM1 signaling system regulates directed cell migration , 2014, Nature Cell Biology.

[87]  G. Mills,et al.  Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression. , 2016, Cancer research.

[88]  Angeleen Fleming,et al.  Compromised autophagy and neurodegenerative diseases , 2015, Nature Reviews Neuroscience.

[89]  Y. Yarden,et al.  Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Z. Kam,et al.  c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.

[91]  Y. Kalaidzidis,et al.  Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes , 2015, eLife.

[92]  Y. Yarden,et al.  Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR , 2013, Proceedings of the National Academy of Sciences.

[93]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[94]  N. Grishin,et al.  EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.

[95]  G. Mills,et al.  Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. , 2007, Developmental cell.

[96]  Careen K. Tang,et al.  Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII , 2006, Cancer biology & therapy.

[97]  P. Bastiaens,et al.  EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling , 2015, eLife.

[98]  Corinne Silva,et al.  Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II , 2004, Molecular and Cellular Biology.

[99]  M. Prados,et al.  An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. , 2011, Cancer discovery.

[100]  Edward S. Kim,et al.  Epidermal growth factor receptor inhibition in lung cancer: status 2012. , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[101]  K. Dittmann,et al.  Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[102]  C. Hoogenraad,et al.  Right Time, Right Place: Probing the Functions of Organelle Positioning. , 2016, Trends in cell biology.

[103]  Sharon E. Miller,et al.  CALM Regulates Clathrin-Coated Vesicle Size and Maturation by Directly Sensing and Driving Membrane Curvature , 2015, Developmental cell.

[104]  Stephanie J. Spielman,et al.  Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2 , 2017, The Journal of cell biology.

[105]  Jiangong Ren,et al.  Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells , 2014, Cell cycle.

[106]  B. Vincenzi,et al.  The biological properties of cetuximab. , 2008, Critical reviews in oncology/hematology.

[107]  P. De Camilli,et al.  Endoplasmic Reticulum-Plasma Membrane Contact Sites. , 2017, Annual review of biochemistry.

[108]  P. P. Di Fiore,et al.  Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. , 2008, Developmental cell.

[109]  Marcel Mettlen,et al.  Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis. , 2017, Developmental cell.

[110]  S. Hanash,et al.  EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. , 2016, Cancer research.

[111]  A. Berns,et al.  Drugging the addict: non‐oncogene addiction as a target for cancer therapy , 2016, EMBO reports.

[112]  C. Antonescu,et al.  Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis , 2015, Molecular biology of the cell.

[113]  J. Kuriyan,et al.  A structural perspective on the regulation of the epidermal growth factor receptor. , 2015, Annual review of biochemistry.

[114]  L. Cantley,et al.  Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. , 2017, Cell reports.

[115]  S. Rhee,et al.  Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[116]  P. Bastiaens,et al.  Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin-Coated Pits , 2015, PloS one.

[117]  Y. Yarden,et al.  The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors , 2015, Oncogene.

[118]  D. Hochhauser,et al.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. , 2011, Cancer research.

[119]  Y. Yarden,et al.  p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.

[120]  Xiaojun Tan,et al.  LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation , 2015, The EMBO journal.

[121]  J. Denu,et al.  Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.

[122]  I. Szumiel Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. , 2006, Cellular signalling.

[123]  M. Satake,et al.  Altered trafficking of mutated growth factor receptors and their associated molecules , 2014, Cellular logistics.

[124]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[125]  J. Rathmell,et al.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. , 2008, Blood.

[126]  R. Pazdur,et al.  FDA drug approval summary: erlotinib (Tarceva) tablets. , 2005, The oncologist.

[127]  D A Lauffenburger,et al.  Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. , 1994, The Journal of biological chemistry.

[128]  H. Wiley,et al.  Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.

[129]  Y. Yarden,et al.  A mutant EGF‐receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling , 2002, The EMBO journal.

[130]  J. Rathmell,et al.  Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. , 2007, Molecular biology of the cell.

[131]  Gur Pines,et al.  The ERBB network: at last, cancer therapy meets systems biology , 2012, Nature Reviews Cancer.

[132]  A. Ciliberto,et al.  Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. , 2012, Physiological reviews.

[133]  G. Scita,et al.  A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination , 2014, The Journal of cell biology.

[134]  J. Douillard,et al.  Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status , 2015, Drugs.

[135]  C. Futter,et al.  An Endosomal NAADP-Sensitive Two-Pore Ca2+ Channel Regulates ER-Endosome Membrane Contact Sites to Control Growth Factor Signaling , 2017, Cell reports.

[136]  Xiaojun Tan,et al.  A Kinase-Independent Role for EGF Receptor in Autophagy Initiation , 2015, Cell.

[137]  Yan Wang,et al.  EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 , 2013, Nature.

[138]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[139]  L. Orci,et al.  Co-localization of 125I-epidermal growth factor and ferritin-low density lipoprotein in coated pits: a quantitative electron microscopic study in normal and mutant human fibroblasts , 1982, The Journal of cell biology.

[140]  Rebecca A. Ihrie,et al.  A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo. , 2017, Cell reports.

[141]  S. Wiemann,et al.  Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer , 2015, Science Signaling.

[142]  Xiaojun Tan,et al.  Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications. , 2016, Trends in cell biology.

[143]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[144]  Seamus J. Martin,et al.  Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.

[145]  Harald Stenmark,et al.  The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins , 2009, Nature.

[146]  Douglas L Black,et al.  EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. , 2013, Cell metabolism.

[147]  D. Rubinsztein,et al.  Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.

[148]  A. Ciliberto,et al.  Threshold-controlled ubiquitination of the EGFR directs receptor fate , 2013, The EMBO journal.

[149]  Y. Kalaidzidis,et al.  Signal processing by the endosomal system. , 2016, Current opinion in cell biology.

[150]  D. Sabatini,et al.  Identification of an oncogenic RAB protein , 2015, Science.

[151]  J. Bussink,et al.  EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[152]  C. Futter,et al.  Annexin A1 Tethers Membrane Contact Sites that Mediate ER to Endosome Cholesterol Transport , 2016, Developmental cell.

[153]  P. Mischel,et al.  mTORC2 in the center of cancer metabolic reprogramming , 2014, Trends in Endocrinology & Metabolism.

[154]  M. Schuldiner,et al.  A Tether Is a Tether Is a Tether: Tethering at Membrane Contact Sites. , 2016, Developmental cell.

[155]  A. Ballabio,et al.  Molecular definitions of autophagy and related processes , 2017, The EMBO journal.

[156]  Matthew Meyerson,et al.  Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.

[157]  G. Mills,et al.  The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers , 2004, Nature Medicine.

[158]  S. Schmid JCB_201705017 2623..2632 , 2017 .

[159]  M. Jaramillo,et al.  Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. , 2006, Experimental cell research.

[160]  Andrew J. Lindsay,et al.  Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments , 2008, The Journal of cell biology.

[161]  Suyong Choi,et al.  PtdIns(4,5)P2 signaling regulates ATG14 and autophagy , 2016, Proceedings of the National Academy of Sciences.

[162]  T. Ravid,et al.  EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization , 2011, PloS one.

[163]  Xuejun Jiang,et al.  Grb2 regulates internalization of EGF receptors through clathrin-coated pits. , 2003, Molecular biology of the cell.

[164]  Derek Toomre,et al.  Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.

[165]  P. P. Di Fiore,et al.  Endocytic control of signaling at the plasma membrane. , 2016, Current opinion in cell biology.

[166]  M. Pierotti,et al.  Targeted Therapies: The Rare Cancer Paradigm , 2010, Molecular oncology.

[167]  Sandra L Schmid,et al.  Advances in analysis of low signal-to-noise images link dynamin and AP2 to the functions of an endocytic checkpoint. , 2013, Developmental cell.

[168]  Mads Lerdrup,et al.  Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor , 2009, Traffic.

[169]  A. Lenferink,et al.  Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.

[170]  C. Arteaga,et al.  Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site* , 1997, The Journal of Biological Chemistry.

[171]  S. Gygi,et al.  Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor , 2010, The Journal of cell biology.